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Growing attention has been given to the quality of life in
several fields of medicine. The concept of quality of life
is not unknown to the glaucoma culture if we recall that the
European Glaucoma Society Guidelines state “the goal of
glaucoma treatment is to maintain the patient’s visual func-
tion and related quality of life (QoL), at a sustainable cost.”
Nevertheless in the past, more attention has been given to
quantitative matters as IOP, visual field, and optic nerve
because those were the ones that can be directly modified
and physicians were less interested in qualitative and subjec-
tive measures as the QoL. Measurements of QoL, on the
other hand, tend to be time consuming and can be strongly
influenced by other factors (general physical health, psycho-
logical state, personality, relationships, wealth, etc.), which
are not necessarily related to the disease itself.
However, there is no doubt that when the physician pays
attention to the claims of the patients, he will realize that
most of their questions are related to everyday issues such
as “will I be able to drive my car? Will I be able to be indepen-
dent in my daily tasks within my home? And will I be able to
go the supermarket two blocks from my house? Will I have
problems reading?”
The same questions are relevant for insurances and gov-
ernments because the disability caused by any disease will
help determine the level at which the benefits of screening
outweigh costs and decide which patient should be treated
and how aggressive treatment should be. Furthermore,
knowing the degree of disability can potentially help to
increase patient safety with appropriate guidelines, to
recognize patients who can benefit from rehabilitation and
evaluate the efficacy of those measures.
Since the first studies on quality of life in glaucoma,
several areas of interest have been identified and explored:
(1) determining the symptoms that are more bothersome
for the patients and correlating them with the stage of
disease; (2) testing and building better methods to investigate
the impact of glaucoma on the QoL; (3) assessing the impact
of glaucoma on mental status; and (4) analyzing the impact
of different therapies on the QoL of glaucoma patients.
(1) Thanks to recent investigations, we are now aware
that vision defects in glaucoma patients are not as
simple as the traditional view of peripheral vision
loss, but they affect several aspects related to a gener-
ally decreased image quality including glare, letters
appearing faded when reading, and needing more
light. Glaucoma patients gave the higher importance
to tasks involving central and near vision (reading)
and to mobility outside the home, whereas the most
frequent complaints were difficulties related to light-
ing and in particular adapting to different levels of
light. Common complaints also included difficulty
in walking, stair climbing, face recognition, and driv-
ing. The relative importance of these problems is
correlated to the degree of visual function and to
the age of the patient. The correlation coefficients
for the lower paracentral and lower peripheral VF
of the better eye were the highest for several sub-
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scales, such as general vision, near vision, distance
vision, social function, mental health, role limitation,
and driving. Although the best correlations were
generally found in the visual field of the better eye,
the best metric to relate disease severity to disability
is still a matter of debate and further work is needed
in the field.
(2) QoL assessment traditionally used patient-reported-
outcome (PRO) questionnaires. More than 30
vision-specific PRO measures have been developed
in the context of glaucoma and can be classified in
three categories: PROs addressing functional status
related to vision, PROs addressing overall QoL, and
PROs assessing other factors related to disease and
treatment (i.e., symptoms, side effects, adherence,
satisfaction, and self-efficacy). Several studies failed
to demonstrate a correlation between QoL and
glaucoma severity especially when PROs were not
specifically designed. Research on the most appropri-
ate type of PRO has been very active. The informa-
tion gathered with questionnaires are subjective and
influenced by many factors other than the disease,
including emotions, concentration, personality, and
desire to please or to mislead. Furthermore, data
from the SEE project showed that 10% of the subjects
have differences between their perception on their
ability to perform activities and their actual perfor-
mance. Nevertheless, responses to questions about
visual ability seem to correlate with clinical objective
measures, which suggests that in the future, it may be
possible to use them to define subgroups in the over-
all population. An active area of research in the last
few years was the development and testing of stan-
dardized, performance-based measures of function
performed in a clinical setting. Potential implica-
tions of the disagreement between subjective and
objective testing will be to investigate why some
patients have discrepancies between self-reported
and performance-based tests. The knowledge of
what an individual with a specific vision problem
can actually do opens the way to develop tools to
improve his performance, lessen his problems,
and actively improve his quality of life. Another
potential and poorly explored area is to follow pro-
spectively the patients to understand how attitudes
and QoL modify as the disease progresses, as the
patient ages, or as other subjective or objective factors
(wealth, social relationships, activities, etc.) change.
(3) Glaucoma doctors always had the clinical impression
that some psychological traits are typical of the glau-
coma patients, but several papers demonstrated that
glaucoma is a significant predictor of depression after
adjustment for demographic factors and multiple
comorbidities with a prevalence estimated around
10%. The finding that objective measures are not cor-
related to depression should alert clinicians that a
high prevalence of depression may be present even
among patients without clinically significant visual
disabilities. Counseling regarding the generally slow
progression rate of the disease may result in a
decreased burden from depression.
(4) The impact of new therapies, minimally invasive sur-
gical procedures, and slow drug-releasing implants
on the patient’s QoL will certainly be a rapid growing
field of investigation. The research in this field may
potentially guide the researchers to select new thera-
pies that have minimal effect on the quality of life
and the agencies to evaluate the general and eco-
nomic impacts of these new therapies on the glau-
coma patients.
We decided to dedicate this special issue to QoL with
the aim to shed light on the quality of life of glaucoma
patients and attract attention of the scientific community
to pursue further investigations leading to a rapid develop-
ment of this field.
A better understanding of patient-reported QoL can
improve the relationship between the patient and the physi-
cian and enhance adherence in choosing the treatment
options on the basis of the patient profile.
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